Your browser doesn't support javascript.
Identification of Presymptomatic and Asymptomatic Cases Using Cohort-Based Testing Approaches at a Large Correctional Facility-Chicago, Illinois, USA, May 2020.
Wadhwa, Ashutosh; Fisher, Kiva A; Silver, Rachel; Koh, Mitsuki; Arons, Melissa M; Miller, David A; McIntyre, Anne F; Vuong, Jeni T; Kim, Kaylee; Takamiya, Mayuko; Binder, Alison M; Tate, Jacqueline E; Armstrong, Paige A; Black, Stephanie R; Mennella, Connie C; Levin, Rebecca; Gubser, Jane; Jones, Bridgette; Welbel, Sharon F; Moonan, Patrick K; Curran, Kathryn; Ghinai, Isaac; Doshi, Reena; Zawitz, Chad J.
  • Wadhwa A; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Fisher KA; Laboratory Leadership Service, CDC, Atlanta, Georgia, USA.
  • Silver R; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Koh M; Epidemic Intelligence Service, CDC, Atlanta, Georgia, USA.
  • Arons MM; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Miller DA; Public Health Institute-CDC Global Health Fellow, Atlanta, Georgia, USA.
  • McIntyre AF; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Vuong JT; Public Health Institute-CDC Global Health Fellow, Atlanta, Georgia, USA.
  • Kim K; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Takamiya M; Epidemic Intelligence Service, CDC, Atlanta, Georgia, USA.
  • Binder AM; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Tate JE; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Armstrong PA; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Black SR; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Mennella CC; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Levin R; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Gubser J; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Jones B; COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Welbel SF; Chicago Department of Public Health, Chicago, Illinois, USA.
  • Moonan PK; Cermak Health Services, Chicago, Illinois, USA.
  • Curran K; Cook County Health, Chicago, Illinois, USA.
  • Ghinai I; Cook County Sherriff's Office, Chicago, Illinois, USA.
  • Doshi R; Cook County Sherriff's Office, Chicago, Illinois, USA.
  • Zawitz CJ; Cermak Health Services, Chicago, Illinois, USA.
Clin Infect Dis ; 72(5): e128-e135, 2021 03 01.
Article in English | MEDLINE | ID: covidwho-955787
ABSTRACT

BACKGROUND:

Coronavirus disease 2019 (COVID-19) continues to cause significant morbidity and mortality worldwide. Correctional and detention facilities are at high risk of experiencing outbreaks. We aimed to evaluate cohort-based testing among detained persons exposed to laboratory-confirmed cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in order to identify presymptomatic and asymptomatic cases.

METHODS:

During 1-19 May 2020, 2 testing strategies were implemented in 12 tiers or housing units of the Cook County Jail, Chicago, Illinois. Detained persons were approached to participate in serial testing (n = 137) and offered tests at 3 time points over 14 days (day 1, days 3-5, and days 13-14). The second group was offered a single test and interview at the end of a 14-day quarantine period (day 14 group) (n = 87).

RESULTS:

224 detained persons were approached for participation and, of these, 194 (87%) participated in ≥1 interview and 172 (77%) had ≥1 test. Of the 172 tested, 19 were positive for SARS-CoV-2. In the serial testing group, 17 (89%) new cases were detected, 16 (84%) on day 1, 1 (5%) on days 3-5, and none on days 13-14; in the day 14 group, 2 (11%) cases were identified. More than half (12/19; 63%) of the newly identified cases were presymptomatic or asymptomatic.

CONCLUSIONS:

Our findings highlight the utility of cohort-based testing promptly after initiating quarantine within a housing tier. Cohort-based testing efforts identified new SARS-CoV-2 asymptomatic and presymptomatic infections that may have been missed by symptom screening alone.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Correctional Facilities / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Correctional Facilities / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid